CS logo
small CS logo
Regional Cancer Program of the Hopital Regional

Sudbury, Ontario, Canada

About Regional Cancer Program of the Hopital Regional


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Regional Cancer Program of the Hopital Regional


During the past decade, Regional Cancer Program of the Hopital Regional conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Regional Cancer Program of the Hopital Regional" #1 collaborator was "Eastern Cooperative Oncology Group" with 3 trials as a collaborator, "National Cancer Institute (NCI)" with 3 trials as a collaborator, "SWOG Cancer Research Network" with 3 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator and "ETOP IBCSG Partners Foundation" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 8 trials.

Clinical Trials Conditions at Regional Cancer Program of the Hopital Regional


According to Clinical.Site data, the most researched conditions in "Regional Cancer Program of the Hopital Regional" are "Breast Cancer" (2 trials), "Lymphoma" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "Regional Cancer Program of the Hopital Regional" in a lesser frequency.

Clinical Trials Intervention Types at Regional Cancer Program of the Hopital Regional


Most popular intervention types in "Regional Cancer Program of the Hopital Regional" are "Drug" (4 trials), "Biological" (1 trials), "Other" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "anastrozole" (1 trials), "bicalutamide" (1 trials), "bortezomib" (1 trials), "buserelin" (1 trials) and "cyclophosphamide" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Regional Cancer Program of the Hopital Regional


The vast majority of trials in "Regional Cancer Program of the Hopital Regional" are 2 trials for "Female" genders, 1 trials for "All" genders and 1 trials for "Male" genders.

Clinical Trials Status at Regional Cancer Program of the Hopital Regional


Currently, there are NaN active trials in "Regional Cancer Program of the Hopital Regional". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Regional Cancer Program of the Hopital Regional, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Regional Cancer Program of the Hopital Regional, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".